NCT01896856 2020-10-06Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1/2 Completed118 enrolled 16 charts